EMEA (Europe, Middle East and Africa) Anti-epileptic Drugs for Pediatrics Market Report 2017

December 2017 | 113 pages | ID: EE230DACD73EN
QYResearch

Abstracts

In this report, the EMEA Anti-epileptic Drugs for Pediatrics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Anti-epileptic Drugs for Pediatrics for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Anti-epileptic Drugs for Pediatrics market competition by top manufacturers/players, with Anti-epileptic Drugs for Pediatrics sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Mylan N.V.
• Cephalon, Inc.
• GlaxoSmithKline plc
• Janssen Pharmaceuticals
• Novartis AG
• Pfizer, Inc.
• Sanofi S.A.
• UCB Pharma Limited
• Sunovion Pharmaceuticals Limited
• Valeant Pharmaceuticals International, Inc.
• Zogenix
• GW Pharmaceuticals
• Insys
• Zynerba

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• First Generation
• Second Generation
• Third Generation

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Clinic
• Hospital
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Anti-epileptic Drugs for Pediatrics Market Report 2017

1 ANTI-EPILEPTIC DRUGS FOR PEDIATRICS OVERVIEW

1.1 Product Overview and Scope of Anti-epileptic Drugs for Pediatrics
1.2 Classification of Anti-epileptic Drugs for Pediatrics
  1.2.1 EMEA Anti-epileptic Drugs for Pediatrics Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Anti-epileptic Drugs for Pediatrics Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 First Generation
  1.2.4 Second Generation
  1.2.5 Third Generation
1.3 EMEA Anti-epileptic Drugs for Pediatrics Market by Application/End Users
  1.3.1 EMEA Anti-epileptic Drugs for Pediatrics Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 EMEA Anti-epileptic Drugs for Pediatrics Market by Region
  1.4.1 EMEA Anti-epileptic Drugs for Pediatrics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Anti-epileptic Drugs for Pediatrics (2012-2022)
  1.5.1 EMEA Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2012-2022)

2 EMEA ANTI-EPILEPTIC DRUGS FOR PEDIATRICS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Anti-epileptic Drugs for Pediatrics Market Competition by Players/Manufacturers
  2.1.1 EMEA Anti-epileptic Drugs for Pediatrics Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Anti-epileptic Drugs for Pediatrics Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Anti-epileptic Drugs for Pediatrics Sale Price by Players (2012-2017)
2.2 EMEA Anti-epileptic Drugs for Pediatrics (Volume and Value) by Type/Product Category
  2.2.1 EMEA Anti-epileptic Drugs for Pediatrics Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Anti-epileptic Drugs for Pediatrics Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Anti-epileptic Drugs for Pediatrics Sale Price by Type (2012-2017)
2.3 EMEA Anti-epileptic Drugs for Pediatrics (Volume) by Application
2.4 EMEA Anti-epileptic Drugs for Pediatrics (Volume and Value) by Region
  2.4.1 EMEA Anti-epileptic Drugs for Pediatrics Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Anti-epileptic Drugs for Pediatrics Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Anti-epileptic Drugs for Pediatrics Sales Price by Region (2012-2017)

3 EUROPE ANTI-EPILEPTIC DRUGS FOR PEDIATRICS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Anti-epileptic Drugs for Pediatrics Sales and Value (2012-2017)
  3.1.1 Europe Anti-epileptic Drugs for Pediatrics Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2012-2017)
3.2 Europe Anti-epileptic Drugs for Pediatrics Sales and Market Share by Type
3.3 Europe Anti-epileptic Drugs for Pediatrics Sales and Market Share by Application
3.4 Europe Anti-epileptic Drugs for Pediatrics Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Anti-epileptic Drugs for Pediatrics Sales Volume by Countries (2012-2017)
  3.4.2 Europe Anti-epileptic Drugs for Pediatrics Revenue by Countries (2012-2017)
  3.4.3 Germany Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2017)
  3.4.4 France Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2017)
  3.4.5 UK Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2017)
  3.4.6 Russia Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2017)
  3.4.7 Italy Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ANTI-EPILEPTIC DRUGS FOR PEDIATRICS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Anti-epileptic Drugs for Pediatrics Sales and Value (2012-2017)
  4.1.1 Middle East Anti-epileptic Drugs for Pediatrics Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2012-2017)
4.2 Middle East Anti-epileptic Drugs for Pediatrics Sales and Market Share by Type
4.3 Middle East Anti-epileptic Drugs for Pediatrics Sales and Market Share by Application
4.4 Middle East Anti-epileptic Drugs for Pediatrics Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Anti-epileptic Drugs for Pediatrics Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Anti-epileptic Drugs for Pediatrics Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2017)
  4.4.4 Israel Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2017)
  4.4.5 UAE Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2017)
  4.4.6 Iran Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2017)

5 AFRICA ANTI-EPILEPTIC DRUGS FOR PEDIATRICS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Anti-epileptic Drugs for Pediatrics Sales and Value (2012-2017)
  5.1.1 Africa Anti-epileptic Drugs for Pediatrics Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2012-2017)
5.2 Africa Anti-epileptic Drugs for Pediatrics Sales and Market Share by Type
5.3 Africa Anti-epileptic Drugs for Pediatrics Sales and Market Share by Application
5.4 Africa Anti-epileptic Drugs for Pediatrics Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Anti-epileptic Drugs for Pediatrics Sales Volume by Countries (2012-2017)
  5.4.2 Africa Anti-epileptic Drugs for Pediatrics Revenue by Countries (2012-2017)
  5.4.3 South Africa Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Anti-epileptic Drugs for Pediatrics Sales and Growth Rate (2012-2017)

6 EMEA ANTI-EPILEPTIC DRUGS FOR PEDIATRICS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Mylan N.V.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anti-epileptic Drugs for Pediatrics Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Mylan N.V. Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Cephalon, Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Anti-epileptic Drugs for Pediatrics Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Cephalon, Inc. Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline plc
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Anti-epileptic Drugs for Pediatrics Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Janssen Pharmaceuticals
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Anti-epileptic Drugs for Pediatrics Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Novartis AG
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Anti-epileptic Drugs for Pediatrics Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Novartis AG Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pfizer, Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Anti-epileptic Drugs for Pediatrics Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer, Inc. Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sanofi S.A.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Anti-epileptic Drugs for Pediatrics Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanofi S.A. Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 UCB Pharma Limited
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Anti-epileptic Drugs for Pediatrics Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Sunovion Pharmaceuticals Limited
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Anti-epileptic Drugs for Pediatrics Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Valeant Pharmaceuticals International, Inc.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Anti-epileptic Drugs for Pediatrics Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Valeant Pharmaceuticals International, Inc. Anti-epileptic Drugs for Pediatrics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Zogenix
6.12 GW Pharmaceuticals
6.13 Insys
6.14 Zynerba

7 ANTI-EPILEPTIC DRUGS FOR PEDIATRICS MANUFACTURING COST ANALYSIS

7.1 Anti-epileptic Drugs for Pediatrics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-epileptic Drugs for Pediatrics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anti-epileptic Drugs for Pediatrics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-epileptic Drugs for Pediatrics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ANTI-EPILEPTIC DRUGS FOR PEDIATRICS MARKET FORECAST (2017-2022)

11.1 EMEA Anti-epileptic Drugs for Pediatrics Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Anti-epileptic Drugs for Pediatrics Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Anti-epileptic Drugs for Pediatrics Price and Trend Forecast (2017-2022)
11.2 EMEA Anti-epileptic Drugs for Pediatrics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Anti-epileptic Drugs for Pediatrics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Anti-epileptic Drugs for Pediatrics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Anti-epileptic Drugs for Pediatrics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Anti-epileptic Drugs for Pediatrics Sales Forecast by Type (2017-2022)
11.7 EMEA Anti-epileptic Drugs for Pediatrics Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Anti-epileptic Drugs for Pediatrics
Figure EMEA Anti-epileptic Drugs for Pediatrics Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Anti-epileptic Drugs for Pediatrics Sales Volume Market Share by Type (Product Category) in 2016
Figure First Generation Product Picture
Figure Second Generation Product Picture
Figure Third Generation Product Picture
Figure EMEA Anti-epileptic Drugs for Pediatrics Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Anti-epileptic Drugs for Pediatrics by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Anti-epileptic Drugs for Pediatrics Market Size (Million USD) by Region (2012-2022)
Figure Europe Anti-epileptic Drugs for Pediatrics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Anti-epileptic Drugs for Pediatrics Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Anti-epileptic Drugs for Pediatrics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Anti-epileptic Drugs for Pediatrics Revenue (Million USD) Status and Forecast by Countries
Figure Africa Anti-epileptic Drugs for Pediatrics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Anti-epileptic Drugs for Pediatrics Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Anti-epileptic Drugs for Pediatrics Sales Volume and Growth Rate (2012-2022)
Figure EMEA Anti-epileptic Drugs for Pediatrics Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Anti-epileptic Drugs for Pediatrics Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Anti-epileptic Drugs for Pediatrics Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Anti-epileptic Drugs for Pediatrics Sales Share by Players (2012-2017)
Figure 2016 Anti-epileptic Drugs for Pediatrics Sales Share by Players
Figure 2017 Anti-epileptic Drugs for Pediatrics Sales Share by Players
Figure EMEA Anti-epileptic Drugs for Pediatrics Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Anti-epileptic Drugs for Pediatrics Revenue (Million USD) by Players (2012-2017)
Table EMEA Anti-epileptic Drugs for Pediatrics Revenue Share by Players (2012-2017)
Table 2016 EMEA Anti-epileptic Drugs for Pediatrics Revenue Share by Players
Table 2017 EMEA Anti-epileptic Drugs for Pediatrics Revenue Share by Players
Table EMEA Anti-epileptic Drugs for Pediatrics Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Anti-epileptic Drugs for Pediatrics Sales Share by Type (2012-2017)
Figure Sales Market Share of Anti-epileptic Drugs for Pediatrics by Type (2012-2017)
Figure EMEA Anti-epileptic Drugs for Pediatrics Sales Market Share by Type (2012-2017)
Table EMEA Anti-epileptic Drugs for Pediatrics Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Anti-epileptic Drugs for Pediatrics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-epileptic Drugs for Pediatrics by Type in 2016
Table EMEA Anti-epileptic Drugs for Pediatrics Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Anti-epileptic Drugs for Pediatrics Sales Share by Application (2012-2017)
Figure Sales Market Share of Anti-epileptic Drugs for Pediatrics by Application (2012-2017)
Figure EMEA Anti-epileptic Drugs for Pediatrics Sales Market Share by Application in 2016
Table EMEA Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Anti-epileptic Drugs for Pediatrics Sales Share by Region (2012-2017)
Figure Sales Market Share of Anti-epileptic Drugs for Pediatrics by Region (2012-2017)
Figure EMEA Anti-epileptic Drugs for Pediatrics Sales Market Share in 2016
Table EMEA Anti-epileptic Drugs for Pediatrics Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Anti-epileptic Drugs for Pediatrics Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Anti-epileptic Drugs for Pediatrics by Region (2012-2017)
Figure EMEA Anti-epileptic Drugs for Pediatrics Revenue Market Share Regions in 2016
Table EMEA Anti-epileptic Drugs for Pediatrics Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate (2012-2017)
Table Europe Anti-epileptic Drugs for Pediatrics Sales (K Pcs) by Type (2012-2017)
Table Europe Anti-epileptic Drugs for Pediatrics Market Share by Type (2012-2017)
Figure Europe Anti-epileptic Drugs for Pediatrics Market Share by Type in 2016
Table Europe Anti-epileptic Drugs for Pediatrics Sales (K Pcs) by Application (2012-2017)
Table Europe Anti-epileptic Drugs for Pediatrics Market Share by Application (2012-2017)
Figure Europe Anti-epileptic Drugs for Pediatrics Market Share by Application in 2016
Table Europe Anti-epileptic Drugs for Pediatrics Sales (K Pcs) by Countries (2012-2017)
Table Europe Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries (2012-2017)
Figure Europe Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries (2012-2017)
Figure Europe Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries in 2016
Table Europe Anti-epileptic Drugs for Pediatrics Revenue (Million USD) by Countries (2012-2017)
Table Europe Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2012-2017)
Figure Europe Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2012-2017)
Figure Europe Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries in 2016
Figure Germany Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Anti-epileptic Drugs for Pediatrics Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Anti-epileptic Drugs for Pediatrics Sales (K Pcs) by Type (2012-2017)
Table Middle East Anti-epileptic Drugs for Pediatrics Market Share by Type (2012-2017)
Figure Middle East Anti-epileptic Drugs for Pediatrics Market Share by Type (2012-2017)
Table Middle East Anti-epileptic Drugs for Pediatrics Sales (K Pcs) by Applications (2012-2017)
Table Middle East Anti-epileptic Drugs for Pediatrics Market Share by Applications (2012-2017)
Figure Middle East Anti-epileptic Drugs for Pediatrics Sales Market Share by Application in 2016
Table Middle East Anti-epileptic Drugs for Pediatrics Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Anti-epileptic Drugs for Pediatrics Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Anti-epileptic Drugs for Pediatrics Sales Volume Market Share by Countries in 2016
Table Middle East Anti-epileptic Drugs for Pediatrics Revenue (Million USD) by Countries (2012-2017)
Table Middle East Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2012-2017)
Figure Middle East Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2012-2017)
Figure Middle East Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries in 2016
Figure Saudi Arabia Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Anti-epileptic Drugs for Pediatrics Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Anti-epileptic Drugs for Pediatrics Sales (K Pcs) by Type (2012-2017)
Table Africa Anti-epileptic Drugs for Pediatrics Sales Market Share by Type (2012-2017)
Figure Africa Anti-epileptic Drugs for Pediatrics Sales Market Share by Type (2012-2017)
Figure Africa Anti-epileptic Drugs for Pediatrics Sales Market Share by Type in 2016
Table Africa Anti-epileptic Drugs for Pediatrics Sales (K Pcs) by Application (2012-2017)
Table Africa Anti-epileptic Drugs for Pediatrics Sales Market Share by Application (2012-2017)
Figure Africa Anti-epileptic Drugs for Pediatrics Sales Market Share by Application (2012-2017)
Table Africa Anti-epileptic Drugs for Pediatrics Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries (2012-2017)
Figure Africa Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries (2012-2017)
Figure Africa Anti-epileptic Drugs for Pediatrics Sales Market Share by Countries in 2016
Table Africa Anti-epileptic Drugs for Pediatrics Revenue (Million USD) by Countries (2012-2017)
Table Africa Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2012-2017)
Figure Africa Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries (2012-2017)
Figure Africa Anti-epileptic Drugs for Pediatrics Revenue Market Share by Countries in 2016
Figure South Africa Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Table Mylan N.V. Anti-epileptic Drugs for Pediatrics Basic Information List
Table Mylan N.V. Anti-epileptic Drugs for Pediatrics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mylan N.V. Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Mylan N.V. Anti-epileptic Drugs for Pediatrics Sales Market Share in EMEA (2012-2017)
Figure Mylan N.V. Anti-epileptic Drugs for Pediatrics Revenue Market Share in EMEA (2012-2017)
Table Cephalon, Inc. Anti-epileptic Drugs for Pediatrics Basic Information List
Table Cephalon, Inc. Anti-epileptic Drugs for Pediatrics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cephalon, Inc. Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Cephalon, Inc. Anti-epileptic Drugs for Pediatrics Sales Market Share in EMEA (2012-2017)
Figure Cephalon, Inc. Anti-epileptic Drugs for Pediatrics Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Basic Information List
Table GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Revenue Market Share in EMEA (2012-2017)
Table Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Basic Information List
Table Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Sales Market Share in EMEA (2012-2017)
Figure Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Revenue Market Share in EMEA (2012-2017)
Table Novartis AG Anti-epileptic Drugs for Pediatrics Basic Information List
Table Novartis AG Anti-epileptic Drugs for Pediatrics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis AG Anti-epileptic Drugs for Pediatrics Sales Market Share in EMEA (2012-2017)
Figure Novartis AG Anti-epileptic Drugs for Pediatrics Revenue Market Share in EMEA (2012-2017)
Table Pfizer, Inc. Anti-epileptic Drugs for Pediatrics Basic Information List
Table Pfizer, Inc. Anti-epileptic Drugs for Pediatrics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer, Inc. Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer, Inc. Anti-epileptic Drugs for Pediatrics Sales Market Share in EMEA (2012-2017)
Figure Pfizer, Inc. Anti-epileptic Drugs for Pediatrics Revenue Market Share in EMEA (2012-2017)
Table Sanofi S.A. Anti-epileptic Drugs for Pediatrics Basic Information List
Table Sanofi S.A. Anti-epileptic Drugs for Pediatrics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi S.A. Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi S.A. Anti-epileptic Drugs for Pediatrics Sales Market Share in EMEA (2012-2017)
Figure Sanofi S.A. Anti-epileptic Drugs for Pediatrics Revenue Market Share in EMEA (2012-2017)
Table UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Basic Information List
Table UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Sales Market Share in EMEA (2012-2017)
Figure UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Revenue Market Share in EMEA (2012-2017)
Table Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Basic Information List
Table Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Sales Market Share in EMEA (2012-2017)
Figure Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Revenue Market Share in EMEA (2012-2017)
Table Valeant Pharmaceuticals International, Inc. Anti-epileptic Drugs for Pediatrics Basic Information List
Table Valeant Pharmaceuticals International, Inc. Anti-epileptic Drugs for Pediatrics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals International, Inc. Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals International, Inc. Anti-epileptic Drugs for Pediatrics Sales Market Share in EMEA (2012-2017)
Figure Valeant Pharmaceuticals International, Inc. Anti-epileptic Drugs for Pediatrics Revenue Market Share in EMEA (2012-2017)
Table Zogenix Anti-epileptic Drugs for Pediatrics Basic Information List
Table GW Pharmaceuticals Anti-epileptic Drugs for Pediatrics Basic Information List
Table Insys Anti-epileptic Drugs for Pediatrics Basic Information List
Table Zynerba Anti-epileptic Drugs for Pediatrics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-epileptic Drugs for Pediatrics
Figure Manufacturing Process Analysis of Anti-epileptic Drugs for Pediatrics
Figure Anti-epileptic Drugs for Pediatrics Industrial Chain Analysis
Table Raw Materials Sources of Anti-epileptic Drugs for Pediatrics Major Manufacturers in 2016
Table Major Buyers of Anti-epileptic Drugs for Pediatrics
Table Distributors/Traders List
Figure EMEA Anti-epileptic Drugs for Pediatrics Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Anti-epileptic Drugs for Pediatrics Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Anti-epileptic Drugs for Pediatrics Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Anti-epileptic Drugs for Pediatrics Sales Market Share Forecast by Region (2017-2022)
Table EMEA Anti-epileptic Drugs for Pediatrics Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Anti-epileptic Drugs for Pediatrics Revenue Market Share Forecast by Region (2017-2022)
Table Europe Anti-epileptic Drugs for Pediatrics Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Anti-epileptic Drugs for Pediatrics Sales Market Share Forecast by Countries (2017-2022)
Table Europe Anti-epileptic Drugs for Pediatrics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Anti-epileptic Drugs for Pediatrics Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Anti-epileptic Drugs for Pediatrics Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Anti-epileptic Drugs for Pediatrics Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Anti-epileptic Drugs for Pediatrics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Anti-epileptic Drugs for Pediatrics Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Anti-epileptic Drugs for Pediatrics Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Anti-epileptic Drugs for Pediatrics Sales Market Share Forecast by Countries (2017-2022)
Table Africa Anti-epileptic Drugs for Pediatrics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Anti-epileptic Drugs for Pediatrics Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Anti-epileptic Drugs for Pediatrics Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Anti-epileptic Drugs for Pediatrics Sales Market Share Forecast by Type (2017-2022)
Table EMEA Anti-epileptic Drugs for Pediatrics Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Anti-epileptic Drugs for Pediatrics Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources